Aleafia Health Inc ALEAF

Healthcare Cannabis

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.

GREY:ALEAF - Post by User

Aleafia Health Inc > AH INTEND TO REPAY 25 MLNS CONVERTIBLE DEBENTURE IN CASH

<< Previous

Bullboard Posts

Next >>

Comment by Yojurron Jan 05, 2021 7:51pm

124 Views

Post# 32229784

RE:AH INTEND TO REPAY 25 MLNS CONVERTIBLE DEBENTURE IN CASH

Humanist wrote: Aleafia Health Announces Intention to Repay $25M Convertible Debenture with Cash
by @nasdaq on 5 Jan 2021, 08:30

Repayment provides greater operational flexibility to build on record cannabis revenue realized in Q4 2020

Results in $2M reduction in annual interest payments

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce its intention to repay in cash its 8% unsecured convertible debt (the “Convertible Debt”) which matures on February 2, 2021. The Convertible Debt was issued by Emblem Corp. on February 2, 2018, and Emblem was acquired by the Company on March 14, 2019.

The Company currently has no materially significant senior secured debt, and its facilities are fully unencumbered, providing further flexibility for additional financing if necessary. The repayment will result in a $2 million reduction in annual interest expenses.

“Through continued fiscal discipline over the course of 2020 and our focus on sustainable growth, we are in a position to eliminate near-term debt. We believe that this approach benefits shareholders and clears the path for continued growth in 2021,” said Aleafia Health CEO Geoffrey Benic.

“The path we’ve taken is now delivering clear results, achieving record cannabis revenue in our recently completed fourth quarter. We look forward to building on the quarter’s robust sales growth across every cannabis sales channel, including domestic medical, adult-use, wholesale, and international.”
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health: